FOR IMMEDIATE RELEASE
SEPTEMBER 1, 2021
Katie Edmiston | Marketing Manager
NCODA Expands Patient and Caregiver Resource to Improve Understanding and Outcomes
CAZENOVIA, NY – September 1, 2021 – With the success of the highly utilized NCODA conceived OCE (Oral Chemotherapy Education) online resource, the collaboration with the Oncology Nursing Society (ONS), the Hematology/Oncology Pharmacy Association (HOPA), and the Association of Community Cancer Centers (ACCC), has now expanded to launch the Intravenous Cancer Treatment Education (IVE) website, ivecanceredsheets.com. This website, in joint effort between the oncology healthcare providers, is dedicated to forward thinking and to providing thorough education resources to improve patient understanding.
The IVE website provides healthcare workers the latest education material for Intravenous Cancer Treatments, communicating vital information to help caregivers and their patients. With a committee consisting of representatives from each of the organizations, a development process is structured to produce trusted and reliable education sheets that provide a robust amount of information on individual drugs and combination drug regimens. The sheets include common uses and treatment schedules, supportive medications drug interactions, side effect management and safe handling tips at home following treatment.
The website is an ongoing NCODA led and committee driven project where new regimens will be added ongoing. With the launch of the IVE website, users can access the first 15 sheets and begin providing them to their patients. As additional education sheets are added, the organizations will continue to communicate this information out to their member practices.
NCODA, Inc. is a 501(c)(3) organization. Our Mission is to empower the medically-integrated oncology team to deliver positive, patient-centered outcomes by providing leadership, expertise, quality standards and best practices. For more information about NCODA’s Executive Council and general updates, visit www.ncoda.org.